Dynavax to Present at the William Blair 40th Annual Growth Stock Conference

Rhea-AI Summary

Dynavax Technologies Corporation (Nasdaq: DVAX) announced that CEO Ryan Spencer will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on June 9 at 12:00 p.m. C.T. The presentation will be accessible via the Company’s website under the 'Events & Presentations' section. Dynavax is known for developing novel vaccines, including HEPLISAV-B, approved in 2018 for hepatitis B prevention in adults. The company is also advancing CpG 1018 as a vaccine adjuvant through partnerships.

EMERYVILLE, Calif., May 28, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on Tuesday, June 9, at 12:00 p.m. C.T.

The presentation will be webcast and may be accessed through the “Events & Presentations” page on the “investors” section of the Company’s website at http://investors.dynavax.com/events-presentations.

About Dynavax
Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company launched its first commercial product, HEPLISAV-B^® [Hepatitis B Vaccine (Recombinant), Adjuvanted], in February 2018, following U.S. FDA approval for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.  Dynavax is also advancing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships. For more information, visit www.dynavax.com and follow the company on LinkedIn.

Contacts:

Nicole Arndt
narndt@dynavax.com
510-665-7264

Derek Cole, President
Investor Relations Advisory Solutions
derek.cole@IRadvisory.com

FAQ

When will Dynavax participate in the William Blair conference?

Dynavax will participate in the William Blair 40th Annual Growth Stock Conference on June 9 at 12:00 p.m. C.T.

How can I watch Dynavax's presentation at the conference?

The presentation can be accessed via the 'Events & Presentations' page on Dynavax's investor website.

What is Dynavax known for?

Dynavax is known for developing and commercializing novel vaccines, including HEPLISAV-B for hepatitis B.

What is the ticker symbol for Dynavax Technologies?

The ticker symbol for Dynavax Technologies is DVAX.

What vaccine did Dynavax launch in 2018?

Dynavax launched HEPLISAV-B, a hepatitis B vaccine, in February 2018.